Moderna announces its covid-19 vaccine phase 2/3 study in children 6 months to under 6 years has successfully met its primary endpoint
Two 25 Μg doses of mrna-1273 in participants 6 months to under 6 years met primary endpoint with robust neutralizing antibody titers similar to adults mrna-1273 was generally well tolerated in this age group although not a primary endpoint, statistically significant vaccine efficacy was observed during the omicron wave that was consistent with the lower two-dose effectiveness against omicron seen in adults moderna is moving forward with global regulatory submissions for mrna-1273 for primary vaccination of children 6 months to under 6 years of age additionally, moderna has initiated a submission to the fda for emergency use authorization of mrna-1273 in children 6 to under 12 years of age; mrna-1273 is approved for use in this age group in europe, canada and australia cambridge, ma / accesswire / march 23, 2022 / moderna, inc. (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced positive interim data from the phase 2/3 kidcove study of the moderna covid-19 vaccine (mrna-1273) in children 6 months to under 2 years and 2 years to under 6 years of age. this interim analysis showed a robust neutralizing antibody response in both age groups after a 25 Μg two-dose primary series of mrna-1273 along with a favorable safety profile.
MRNA Ratings Summary
MRNA Quant Ranking
You've reached your free article limit.
Want To Read More Articles?
See what it all means for your stocks with premium tools
Stockprices is a weekly video covering what moved markets
this week, featuring a panel of Stockprices editors. It is published by the
close of trading on Fridays. Hosted by Nathaniel E. Baker, contributing editor,
and featuring: Aaron Task, VP Contributor Content and co-host Stockprices's Alpha
Trader podcast; Brad Olesen, VP News; Steve Alpher, Managing Editor News, co-host
Alpha Trader.
Unsubscribe From All
You successfully activated
“Only Essentials”
Confirm Upgrade
Your subscription will be moved to the annual plan. Service will automatically renew unless cancelled. No Refunds. Click upgrade to confirm.
Stockprices uses Plaid to connect you account
Connect effortlessly
Plaid lets you securely connect your financial accounts in seconds
Your data belongs to you
Plaid doesn't sell personal info, and will only use it with your permission